$158000 ALS drug pulled from market after failing in large clinical trial - Ars Technica
arstechnica.comSubmitted by arstechnica3419 in business
The drug is now unavailable to new patients; its maker to lay off 70% of employees.
Submitted by arstechnica3419 in business
The drug is now unavailable to new patients; its maker to lay off 70% of employees.